Quetiapine Clinical Trials

• Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients
  ClinicalTrials.gov Identifier: NCT00097032 - Active, not recruiting
  Bipolar Disorder
  
• Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00113295 - Active, not recruiting
  Anxiety Disorder
  
• Interaction between Cocaine and Quetiapine - 1
  ClinicalTrials.gov Identifier: NCT00087750 - Active, not recruiting
  Cocaine-Related Disorders
  
• Quetiapine Treatment for Symptoms Associated with Borderline Personality Disorder
  ClinicalTrials.gov Identifier: NCT00122070 - Recruiting
  Borderline Personality Disorder
  
• Efficacy of Quetiapine in the Treatment of Patients with Schizophrenia and a Comorbid Substance Use Disorder.
  ClinicalTrials.gov Identifier: NCT00156715 - Active, not recruiting
  Schizophrenia; Dual Diagnosis; Schizoaffective Disorder; Psychotic Disorder; Substance Abuse; Alcohol Abuse
  
• Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic
  ClinicalTrials.gov Identifier: NCT00428350 - Active, not recruiting
  Schizophrenia
  
• Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect
  ClinicalTrials.gov Identifier: NCT00534222 - Active, not recruiting
  Mania; Schizophrenia
  
• New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia
  ClinicalTrials.gov Identifier: NCT00161018 - Active, not recruiting
  Schizophrenia
  
• Quetiapine and the Dopaminergic Epigenetic Control
  ClinicalTrials.gov Identifier: NCT00370500 - Recruiting
  Schizophrenia
  
• A Study of Relapse Prevention and the Effectiveness of Long-Acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schiozaffective Disorder
  ClinicalTrials.gov Identifier: NCT00216476 - Active, not recruiting
  Schizophrenia; Psychotic Disorders
  
• Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients
  ClinicalTrials.gov Identifier: NCT00396214 - Recruiting
  Schizophrenia
  
• An Open-Label Study of Quetiapine Added to Oros Methylphenidate in the Treatment of ADHD and Aggressive Behavior
  ClinicalTrials.gov Identifier: NCT00198211 - Active, not recruiting
  Attention-Deficit/Hyperactivity Disorder, Combined Type; Disruptive Behavior Disorder
  
• A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room
  ClinicalTrials.gov Identifier: NCT00457366 - Recruiting
  Agitation
  
• Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone
  ClinicalTrials.gov Identifier: NCT00406315 - Recruiting
  Schizophrenia or Schizoaffective Disorder
  
• Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms
  ClinicalTrials.gov Identifier: NCT00277667 - Active, not recruiting
  Bipolar Disorder
  
• Quetiapine for the Treatment of Insomnia in Alzheimer''s Disease
  ClinicalTrials.gov Identifier: NCT00232570 - Not yet recruiting
  Alzheimer''s Disease
  
• Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-Episode Psychosis-a Pilot Study
  ClinicalTrials.gov Identifier: NCT00511277 - Recruiting
  Schizophrenia
  
• Treatment and Outcome of Early Onset Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00048802 - Active, not recruiting
  Bipolar Disorder
  
• Naturalistic Study, Comparison of Divalproex ER and Quetiapine for Adults With Acute Mania or Mixed Episodes
  ClinicalTrials.gov Identifier: NCT00397020 - Recruiting
  Bipolar Disorder
  
• Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00227305 - Active, not recruiting
  Schizophrenia; Bipolar I Disorder
  
• A Randomized, Double-Blind, Placebo-Controlled Add-On Trial Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence
  ClinicalTrials.gov Identifier: NCT00223249 - Active, not recruiting
  Bipolar Disorder; Alcohol Abuse/Dependence
  
• A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-Release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00309699 - Active, not recruiting
  Bipolar Disorder; Mood Disorders
  
• Quetiapine Treatment for Post-Traumatic Stress Disorder (PTSD)
  ClinicalTrials.gov Identifier: NCT00237393 - Recruiting
  PTSD
  
• Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders
  ClinicalTrials.gov Identifier: NCT00252226 - Recruiting
  Bipolar Disorder
  
• Quetiapine Augmentation for Treatment-Resistant PTSD
  ClinicalTrials.gov Identifier: NCT00292370 - Recruiting
  Stress Disorders, Post-Traumatic; Combat Disorders
  
• Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients with Schizophrenia and Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00090012 - Completed
  Schizophrenia
  
• A Non-Interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine)
  ClinicalTrials.gov Identifier: NCT00533260 - Recruiting
  Bipolar Disorder; Schizophrenia
  
• The Effects of Quetiapine (Seroquel XR) on Sleep During Alcohol Abstinence
  ClinicalTrials.gov Identifier: NCT00434876 - Recruiting
  Alcoholism; Sleep Initiation and Maintenance Disorders
  
• Quetiapine Fumarate (SEROQUEL) and Placebo in the Treatment of Acutely Ill Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00085891 - Completed
  Schizophrenia
  
• Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00090324 - Completed
  Schizophrenia
  
• Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-Compulsive Disorder Patients
  ClinicalTrials.gov Identifier: NCT00564564 - Active, not recruiting
  Obsessive Compulsive Disorder
  
• Quetiapine and Cognition
  ClinicalTrials.gov Identifier: NCT00517387 - Not yet recruiting
  Unipolar Depression
  
• BMI and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine.
  ClinicalTrials.gov Identifier: NCT00312598 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder; Mood Disorders With Psychotic Features
  
• Group Cognitive Behavioral Therapy (CBT I) Vs. Quetiapine for Residual Insomnia Impairing Recovery Among Elderly With Stable Major Affective Disorders
  ClinicalTrials.gov Identifier: NCT00462618 - Recruiting
  Insomnia
  
• Switching Medication to Treat Schizophrenia
  ClinicalTrials.gov Identifier: NCT00044655 - Recruiting
  Schizophrenia
  
• Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children and Adolescent Patients with Bipolar I Mania
  ClinicalTrials.gov Identifier: NCT00090311 - Completed
  Bipolar Disorder
  
• Double-Blind Placebo-Controlled Trial of Quetiapine in Anorexia Nervosa
  ClinicalTrials.gov Identifier: NCT00518973 - Recruiting
  Anorexia Nervosa
  
• Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia
  ClinicalTrials.gov Identifier: NCT00231101 - Recruiting
  Smoking Behavior in Schizophrenia
  
• Quetiapine Induced Neuroplasticity in Schizophrenic Patients: A Combined TMS and VBM Study
  ClinicalTrials.gov Identifier: NCT00554658 - Not yet recruiting
  Schizophrenia
  
• Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania
  ClinicalTrials.gov Identifier: NCT00393978 - Recruiting
  Bipolar Disorder; Cannabis-Related Disorder
  
• High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00297947 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Quetiapine Efficacy in Bipolar Depression Study
  ClinicalTrials.gov Identifier: NCT00523601 - Recruiting
  Bipolar Depression
  
• Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study
  ClinicalTrials.gov Identifier: NCT00561587 - Recruiting
  Alcohol Relaps Prevention; Alcoholism; Alcohol Drinking; Alcohol Consumption; Alcohol Abuse
  
• A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence
  ClinicalTrials.gov Identifier: NCT00227123 - Recruiting
  Bipolar Disorder; Cocaine Dependence; Amphetamine Dependence
  
• Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00181883 - Recruiting
  Bipolar Disorder; Mania
  
• Quetiapine Fumarate (SEROQUEL) used as an Adjunct to Mood Stabilizers in the Treatment of Bipolar I Disorders
  ClinicalTrials.gov Identifier: NCT00107731 - Completed
  Bipolar Disorder
  
• Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency
  ClinicalTrials.gov Identifier: NCT00498628 - Not yet recruiting
  Alcoholism; Alcohol Abuse
  
• Methamphetamine-Quetiapine Interactions in Humans
  ClinicalTrials.gov Identifier: NCT00567866 - Not yet recruiting
  Methamphetamine Dependence
  
• An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence
  ClinicalTrials.gov Identifier: NCT00223210 - Recruiting
  Bipolar Disorder; Cocaine Dependence
  
• Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00306540 - Recruiting
  Post-Traumatic Stress Disorder
  
• Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD
  ClinicalTrials.gov Identifier: NCT00579280 - Recruiting
  Bipolar Disorder; Panic Disorder; Generalized Anxiety Disorder
  
• "A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder"
  ClinicalTrials.gov Identifier: NCT00232414 - Completed
  Bipolar I Disorder; With Acute Depressive Episode
  
• Evaluating Quetiapine Fumarate (SEROQUEL) in the Treatment of Alcohol Dependency in Patients with Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00114686 - Completed
  Bipolar Disorder; Alcoholism
  
• Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients with Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00060489 - Completed
  Bipolar Disorder; Depression, Bipolar
  
• Seroquel Acute Manic
  ClinicalTrials.gov Identifier: NCT00139074 - Active, not recruiting
  Bipolar I Disorder (DSM-IV 296.01, DSM-IV 296.4, DSM-IV 296.61)
  
• Quetiapine for Primary Insomnia Patients : A Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00328822 - Not yet recruiting
  Primary Insomnia
  
• Quetiapine for Bipolar Disorder and Alcohol Dependence
  ClinicalTrials.gov Identifier: NCT00457197 - Recruiting
  Bipolar Disorder; Alcohol Dependence
  
• Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00018642 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.
  ClinicalTrials.gov Identifier: NCT00521365 - Not yet recruiting
  Bipolar Disorder; Affective Psychosis, Bipolar; Mania; Manic Disorder; Manic State
  
• Venlafaxine Augmentation
  ClinicalTrials.gov Identifier: NCT00253266 - Not yet recruiting
  Treatment Resistant Depression
  
• Effect of Quetiapine on Negative Symptoms and Cognition
  ClinicalTrials.gov Identifier: NCT00305422 - Completed
  Schizophrenia
  
• The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients
  ClinicalTrials.gov Identifier: NCT00295412 - Completed
  Schizophrenia; Substance Use Disorders
  
• Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.
  ClinicalTrials.gov Identifier: NCT00314210 - Completed
  Anxiety Disorders
  
• Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis
  ClinicalTrials.gov Identifier: NCT00449397 - Completed
  Psychosis
  
• Fast Titration Of Quetiapine Versus Currently Approved Titration
  ClinicalTrials.gov Identifier: NCT00254813 - Completed
  Psychotic Disorders
  
• Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients
  ClinicalTrials.gov Identifier: NCT00254787 - Completed
  Schizophrenia
  
• Quetiapine Fumarate Bipolar Maintenance Monotherapy
  ClinicalTrials.gov Identifier: NCT00314184 - Completed
  Bipolar Disorder
  
• Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-Release) Compared With Quetiapine in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00334126 - Completed
  Schizophrenia
  
• Schizophrenia Sensory Gating Deficit With Quetiapine
  ClinicalTrials.gov Identifier: NCT00536783 - Completed
  Schizophrenia
  
• Antipsychotic Response in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00018668 - Completed
  Schizophrenia
  
• CATIE- Schizophrenia Trial
  ClinicalTrials.gov Identifier: NCT00014001 - Completed
  Schizophrenia
  
• Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling
  ClinicalTrials.gov Identifier: NCT00254774 - Completed
  Bipolar Disorder
  
• Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders
  ClinicalTrials.gov Identifier: NCT00326144 - Completed
  Major Depressive Disorder
  
• Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders
  ClinicalTrials.gov Identifier: NCT00326105 - Completed
  Major Depressive Disorder
  
• The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking Environment
  ClinicalTrials.gov Identifier: NCT00407199 - Completed
  Social Phobia
  
• Open label trial exploring a switch from oral medications, to risperidone depot microspheres
  ClinicalTrials.gov Identifier: NCT00034775 - Completed
  Schizophrenia
  
• Confirmatory Study of Seroquel® in the Treatment of Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00083954 - Completed
  Bipolar Disorder
  
• A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents
  ClinicalTrials.gov Identifier: NCT00221468 - Completed
  Mood Disorders
  
• Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients
  ClinicalTrials.gov Identifier: NCT00254748 - Completed
  Borderline Personality Disorder
  
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00321490 - Completed
  Major Depressive Disorder
  
• A comparison of Seroquel vs. Risperidone in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00034905 - Completed
  Schizophrenia
  
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00320268 - Completed
  Major Depressive Disorder
  
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00329264 - Completed
  Generalized Anxiety Disorder
  
• A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI’s, and SNRI’s Treatment in Major Depression With Anxiety
  ClinicalTrials.gov Identifier: NCT00229645 - Completed
  Major Depression With Comorbid Anxiety Symptoms
  
• Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00278941 - Completed
  Major Depressive Disorder
  
• Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder
  ClinicalTrials.gov Identifier: NCT00182013 - Completed
  Bipolar Spectrum Disorder
  
• Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)
  ClinicalTrials.gov Identifier: NCT00043849 - Completed
  Dementia; Parkinson Disease
  
• CATIE-Alzheimer's Disease Trial
  ClinicalTrials.gov Identifier: NCT00015548 - Completed
  Alzheimer's Disease
  
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00329446 - Completed
  Generalized Anxiety Disorder
  
• Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study
  ClinicalTrials.gov Identifier: NCT00318539 - Completed
  Obsessive Compulsive Disorder
  
• Treatment of Depression With Quetiapine
  ClinicalTrials.gov Identifier: NCT00174603 - Suspended
  Major Depression With Psychotic Features
  
• Quetiapine for Cocaine Use and Cravings
  ClinicalTrials.gov Identifier: NCT00232336 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Quetiapine Augmentation in Severe Obsessive Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00254735 - Completed
  Obsessive Compulsive Disorder
  
• Quetiapine in Social Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00215254 - Completed
  Social Anxiety Disorder
  
• Seroquel plus Mood Stabilizer Compared to Placebo plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00081380 - Completed
  Bipolar Disorder
  
• Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients
  ClinicalTrials.gov Identifier: NCT00375557 - Terminated
  Alzheimer's Disease; Dementia; Behavioral Symptoms
  
• Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00457899 - Terminated
  Schizophrenia; Schizoaffective Disorders; Psychotic Disorders
  
• Efficacy of Quetiapine in Generalised Social Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00302770 - Terminated
  Social Anxiety Disorder